Multimodal treatment of oesophageal cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 6, 2007, Pages 947-963

  Veuillez, Véronique ^d   Rougier, Philippe ^a,b   Seitz, Jean François ^c  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c TIMONE HOSPITAL   (France)

^d NONE

Author keywords

neoadjuvant chemotherapy; oesophageal cancer; radiochemotherapy

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; DOCETAXEL; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; MITOMYCIN C; NAVELBINE; PACLITAXEL; PHOTOFRIN; PHOTOSENSITIZING AGENT; VINBLASTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INOPERABLE CANCER; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RADIATION DOSE; SUPERFICIAL CANCER; SURGICAL TECHNIQUE; SURVIVAL RATE; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; PATHOLOGY; PATIENT SELECTION; REVIEW; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASM STAGING; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 36748999942     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.10.005     Document Type: Article

References (70)

1. Enzinger P.C., and Mayer R.J. Esophageal cancer. N Engl J Med 349 (2003) 2241-2252
2. Giovannini M., Monges G., Seitz J.F., et al. Distant lymph node metastasis in esophageal cancer: impact of endoscopic ultrasound-guided biopsy. Endoscopy 31 (1999) 536-540
3. van Westreenen H.L., Heeren P.A., van Dullemen H.M., et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 9 (2005) 54-61
4. van Westreenen H.L., Westerterp M., Jager P.L., et al. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med 46 (2005) 1321-1325
5. Krasna M.J., Reed C.E., Nedzwiecki D., et al. CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging oesophageal cancer. Ann Thorac Surg 71 (2001) 1073-1079
6. Stein H.J., Kraemer S.J.M., Feussner H., et al. Clinical value of diagnostic laparoscopy with laparoscopic ultrasound in patients with cancer of the esophagus or cardia. J Gastrointest Surg 2 (1997) 167-173
7. Bonvalot S., Bouvard N., Lothaire P., et al. Contribution of cervical ultrasound fine needle aspiration biopsy to the stating of thoracic oesophageal carcinoma. Eur J Cancer 32A (1996) 893-895
8. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
9. Tio T.L., Coene P.P., Den Hartog Jager F.C.A., et al. Preoperative TNM classification of esophageal carcinoma by endosonography. Hepato-gastroenterol 37 (1990) 376-381
10. Maingon P., d'Hombres A., Truc G., et al. High dose rate brachytherapy for superficial cancer of the esophagus. Int J Radiat Oncol Biol Phys 46 (2000) 71-76
11. Kodama M., and Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123 (1998) 432-439
12. Inoue H. Endoscopic mucosal resection for esophageal and gastric mucosal cancers. Can J Gastroenterol 12 (1998) 355-359
13. Barr H. Photodynamic therapy in Barrett's oesophagus and early oesophageal cancer. Acta Endoscopica 33 (2003) 4
14. Sibille A., Lambert R., Souquet J.C., et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 108 (1995) 337-344
15. Fumagalli U. Panel of experts. Resective surgery for cancer of the thoracic esophagus. Results of a Consensus Conference at the VIth World Congress of the International Society for Diseases of the Esophagus. Dis Esoph 9 Suppl 1 (1996) 30-38
16. Hermanek P. 1992 Tumor classification/development. Langenbecks Arch Chir Suppl Kongressbd (1992) 40-45
17. Mariette C., Castel B., Balon J.M., et al. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 29 (2003) 588-593
18. Casson A., Darnton J., Subramanian S., et al. What is the optimal distal resection margin for esophageal carcinoma?. Ann Thorac Surg 69 (2000) 205-209
19. Skinner D.B. En bloc resection of neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 85 (1983) 59-71
20. Killinger W.A., Rice T.W., Adelstein D.J., et al. Stage II esophageal carcinoma. The significance of T and N. J Thorac Cardiovasc Surg 111 (1996) 935-940
21. Luketich J., Alvelo Rivera M., Buenaventura P.O., et al. Minimally invasive esophagectomy. Outcomes in 222 patients. Ann Surg 238 (2003) 486-495
22. Lerut T., Coosemans W., Decker G., et al. Extended surgery of cancer of the esophagus and gastroesophageal junction. J Surg Res 117 (2004) 58-63
23. Collard J.M., Otte J.B., Fiasse R., et al. Skeletonizing en bloc esophagectomy for cancer. Ann Surg 234 (2001) 25-32
24. Bumm R., and Wong R.J. More or less surgery for esophageal cancer: extent of lymphadenectomy in esophagectomy for squamous cell esophageal carcinoma. How much is necessary. Dis Esoph 7 (1994) 151-155
25. Igaki H., Tachimori Y., and Kato H. Improvised survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239 (2004) 483-490
26. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117-2127
27. Branagan G., and Davies N. Early impact of centralization of oesophageal cancer surgery services. Br J Surg 91 (2004) 1630-1632
28. Al-Sarraf M., Martz K., Herskovic A., et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15 (1997) 277-284
29. Herskovic A., Martz K., Al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
30. Smith T., Ryan L.M., Douglass H.O., et al. Combined chemoradiotherapy versus radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42 (1998) 269-276
31. Araujo C.M., Araujo C.M., Souhami L., et al. A randomized trial comparing radiation therapy versus concomitant radiation and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67 (1991) 2258-2261
32. Slabber C.F., Nel J.S., Schoeman L., et al. Randomized study of radiotherapy alone versus radiotherapy+5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 21 (1998) 462-465
33. Wobbes T., Baron B., Paillot B., et al. Prospective randomized study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 37 (2001) 470-477
34. Stahl M., Stuschke M., Lehmann N., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 (2005) 2310-2317
35. Bedenne L., Michel P., Bouche O., et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25 (2007) 1160-1168
36. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
37. Seitz J.F., Jacob J., Lapalus D., et al. Etude nationale randomisée (FNLCC-FFCD 9305) de radio-chimio (RC) dans les cancers épidermoides del'oesophage (CEO): resultants à 5 ans et analyse des facteurs pronostiques. Gastorenterol Clin Biol 27 (2003) A54
38. Arnott S.J., Duncan W., Gignoux M., et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (oesophageal cancer collaborative group). Int J Radiation Oncology Biol Phys 41 (1998) 579-583
39. Bates B.A., Detterbeck F.C., Bernard S.A., et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14 (1996) 156-163
40. Walsh T., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 337 (1996) 161-167
41. Gebski V., Burmeister B., Smithers B.M., et al. Survival benefit from neoadjuvant chemoradiotherapy or chemotherapy in esophageal carcinoma: a meta-analysis. Lancet Oncol 8 (2007) 226-234
42. Piessen G., Briez N., Triboulet J.P., et al. Patients with locally advanced oesophageal carcinoma non responder to radiochemotherapy: who will benefit from surgery?. Ann Surg Oncol 14 (2007) 2036-2044
43. Dresner S.M., and Griffin S.M. Pattern of recurrence following radical esophagectomy with two-field lymphadenectomy. Br J Surg 87 (2000) 1426-1433
44. Mariette C., Balon J.M., Piessen G., et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 97 (2003) 1616-1623
45. Medical Research Council Oesophageal Cancer Working party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359 (2002) 1727-1733
46. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 (1998) 1979-1984
47. Ando N., Iizuka T., Ide H., et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 21 (2003) 4592-4596
48. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
49. Ychou M., Pignon J.P., Lasser P., et al. Phase III preliminary results of preoperative fluorouracil (F) and cisplatin (P) versus surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC 94012-FFCD 9703 trial. Proc ASCO J Clin Oncol 24 (2006) 184S
50. Bleiberg H., Conroy T., Paillot B., et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 33 (1997) 1216-1220
51. Mitry E., Taieb J., Artru P., et al. Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma. Ann Oncol 15 (2004) 765-769
52. Ilson D.H., Saltz L., Enzinger P., et al. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 17 (1999) 3270-3275
53. Ajani J.A., Baker J., Pisters P.W., et al. CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study. Cancer 94 (2002) 641-646
54. Kroep J.R., Pinedo H.M., Giaccone G., et al. Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer. Ann Oncol 15 (2004) 230-235
55. Conroy T., Etienne P.L., Adenis A., et al. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 13 (2002) 721-729
56. Ilson D.H., Forastiere A., Arquette M., et al. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J 6 (2000) 316-323
57. Ilson D.H., Ajani J., Bhalla K., et al. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 16 (1998) 1826-1834
58. Assersohn L., Brown G., Cunningham D., et al. Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. Ann Oncol 15 (2004) 64-69
59. Hochain P., Michel P., and Ducrotté P. Les prothèses métalliques expansives œsophagiennes. HepatoGastro 5 (1998) 303-311
60. Mambrini P., Audibert P., Barthet M., et al. Palliative treatment of esophageal neoplastic stenosis using bipolar electrocoagulation probe. Gastroenterol Clin Biol 20 (1996) 844-851
61. Bourke M.J., Hope R.L., Chu G., et al. Laser palliation of inoperable malignant dysphagia: initial and at death. Gastrointest Endosc 43 (1996) 29-32
62. Wahab P.J., Mulder C.J., den Hartog G., et al. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy 29 (1997) 176-181
63. Seitz J.F., Dahan L., Jacob J., et al. French guideline, esophagus cancer. Gastroenterol Clin Biol 30 (2006) 2S5-2S15
64. Rice T.W., Mason D.P., Murthy S.C., et al. T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg 133 (2007) 317-324
65. Kok T., Lanschot J., Siersema P., et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized control trial (Abstract 984). Proc Am Soc Clin Oncol 16 (1997) 277A
66. Law S., Fok M., Chow S., et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114 (1997) 210-217
67. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
68. Burmeister B.H., Smithers B.M., Gebski V., et al. Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6 (2005) 659-668
69. Lee J.L., Park S.I., Kim S.B., et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15 (2004) 947-954
70. In: Sobin L.H., and Wittekind C. (Eds). TNM Classification of Malignant Tumours. 6th ed (2002), Wiley-Liss, UICC, New York